Kenia Moreno Amador

Ms. Kenia Moreno Amador

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
PFPedro Félix
Pedro Félix
MMMoisés Armides Franco Molina
Moisés Armides Franco Molina
PGPaola Leonor García
Paola Leonor García
HPHeriberto Prado-Garcia
Heriberto Prado-Garcia
DTDIANA ZARATE TRIVIÑO
DIANA ZARATE TRIVIÑO
CRCristina Padilla Rodríguez-Padilla
Cristina Padilla Rodríguez-Padilla
Breast cancer is the most diagnosed type of cancer worldwide and the second cause of death in women. Triple-negative breast cancer (TNBC) is the most aggressive, and due to the lack of specific targets, it is considered the most challenging subtype to treat and the subtype with the worst prognosis. The present study aims to determine the antitumor effect of beta-D-glucose-reduced silver nanoparticles (AgNPs-G) in a murine model of TNBC, as well as to study its effect on the tumor microenvironment. In an airbag model with 4T1 tumor cell implantation, the administration of AgNPs-G or doxorubicin showed antitumoral activity. Using immunohistochemistry it was demonstrated that treatment with AgNPs-G decreased the expression of PCNA, IDO, and GAL-3 and increased the expression of Caspase-3. In the tumor microenvironment, the treatment increased the percentage of memory T cells and innate effector cells and decreased CD4+ cells and regulatory T cells. There was also an increase in the levels of TNF-α, IFN-γ, and IL-6, while TNF-α was increased in serum. In conclusion, we suggest that AgNPs-G treatment has an antitumor effect that is demonstrated by its ability to remodel the tumor microenvironment in mice with TNBC.

30 October 2026 in Veterinary Sciences
Verified
Journal Article
Open access
PDF file
DHDavid Hernández
David Hernández
PGPaola Leonor García
Paola Leonor García
KAKenia Moreno Amador
Kenia Moreno Amador
JKJorge R. Kawas
Jorge R. Kawas
YZYareellys Ramos Zayas
Yareellys Ramos Zayas
MMMoisés Armides Franco Molina
Moisés Armides Franco Molina
Trace minerals are essential cofactors for antioxidant enzymes and immune signaling, yet their status is frequently compromised during stress (weaning, feedlot arrival) due to pre-existing dietary deficiencies, transient reductions in nutrient intake, and acute-phase inflammatory redistribution, increasing bovine respiratory disease (BRD) risk. This critical narrative review integrates the metabolic and immunological pathways of these minerals, highlighting the host’s “nutritional immunity” during acute-phase responses. It contrasts continuous, intake-dependent oral supplementation with rapid, transient injectable routes. Furthermore, it evaluates injectable chemical forms: ethylenediaminetetraacetic acid (EDTA) chelates, upon which most evidence rests, versus gluconates, clarifying that any metabolic advantages of the latter remain strictly hypothetical in the absence of direct comparative cattle trials. While injectables rapidly elevate systemic mineral concentrations, inferences drawn from the synthesized body of evidence indicate that productive and health benefits are inconsistent, primarily favoring high-risk or deficient cattle. Rather than an experimentally validated protocol, the authors propose a theoretical decision model that positions injectable mineral as a targeted “preload” before or during immunological challenges, while oral supplementation serves as the indispensable baseline to maintain reserves. To refine this theoretical approach, further research is needed to address critical knowledge gaps, particularly through efficacy trials that simultaneously evaluate baseline mineral status, immune response, disease incidence, and production performance across different injectable formulations.